These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 22039877)

  • 1. Epigenetic multiple modulators.
    Álvarez R; Altucci L; Gronemeyer H; de Lera AR
    Curr Top Med Chem; 2011 Nov; 11(22):2749-87. PubMed ID: 22039877
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epigenetic polypharmacology: from combination therapy to multitargeted drugs.
    de Lera AR; Ganesan A
    Clin Epigenetics; 2016; 8():105. PubMed ID: 27752293
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting epigenetic enzymes for drug discovery.
    Copeland RA; Olhava EJ; Scott MP
    Curr Opin Chem Biol; 2010 Aug; 14(4):505-10. PubMed ID: 20621549
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Current and upcoming approaches to exploit the reversibility of epigenetic mutations in breast cancer.
    Falahi F; van Kruchten M; Martinet N; Hospers GA; Rots MG
    Breast Cancer Res; 2014 Jul; 16(4):412. PubMed ID: 25410383
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Design of small molecule epigenetic modulators.
    Pachaiyappan B; Woster PM
    Bioorg Med Chem Lett; 2014 Jan; 24(1):21-32. PubMed ID: 24300735
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exploring the epigenetic drug discovery landscape.
    Prachayasittikul V; Prathipati P; Pratiwi R; Phanus-Umporn C; Malik AA; Schaduangrat N; Seenprachawong K; Wongchitrat P; Supokawej A; Prachayasittikul V; Wikberg JE; Nantasenamat C
    Expert Opin Drug Discov; 2017 Apr; 12(4):345-362. PubMed ID: 28276705
    [TBL] [Abstract][Full Text] [Related]  

  • 7. EDITORIAL: Medicinal Chemistry of Molecular and Epigenetic Targets and Dug Development.
    Zhang L
    Curr Top Med Chem; 2017; 17(15):1669. PubMed ID: 28589850
    [No Abstract]   [Full Text] [Related]  

  • 8. Epigenetic small molecule modulators of histone and DNA methylation.
    Hauser AT; Robaa D; Jung M
    Curr Opin Chem Biol; 2018 Aug; 45():73-85. PubMed ID: 29579619
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prospects for the development of epigenetic drugs for CNS conditions.
    Szyf M
    Nat Rev Drug Discov; 2015 Jul; 14(7):461-74. PubMed ID: 26000723
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epigenomic networking in drug development: from pathogenic mechanisms to pharmacogenomics.
    Cacabelos R
    Drug Dev Res; 2014 Sep; 75(6):348-65. PubMed ID: 25195579
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epigenetic drug discovery: a success story for cofactor interference.
    Ganesan A
    Philos Trans R Soc Lond B Biol Sci; 2018 Jun; 373(1748):. PubMed ID: 29685973
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Common non-epigenetic drugs as epigenetic modulators.
    Lötsch J; Schneider G; Reker D; Parnham MJ; Schneider P; Geisslinger G; Doehring A
    Trends Mol Med; 2013 Dec; 19(12):742-53. PubMed ID: 24054876
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ureas: Applications in Drug Design.
    Jagtap AD; Kondekar NB; Sadani AA; Chern JW
    Curr Med Chem; 2017; 24(6):622-651. PubMed ID: 27897114
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Insights from pharmacological similarity of epigenetic targets in epipolypharmacology.
    Naveja JJ; Medina-Franco JL
    Drug Discov Today; 2018 Jan; 23(1):141-150. PubMed ID: 29038074
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An overview of epigenetic agents and natural nutrition products targeting DNA methyltransferase, histone deacetylases and microRNAs.
    Huang D; Cui L; Ahmed S; Zainab F; Wu Q; Wang X; Yuan Z
    Food Chem Toxicol; 2019 Jan; 123():574-594. PubMed ID: 30408543
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeting components of epigenome by small molecules.
    You JS; Han JH
    Arch Pharm Res; 2014 Nov; 37(11):1367-74. PubMed ID: 25070764
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Medicinal chemistry insights in the discovery of novel LSD1 inhibitors.
    Wang X; Huang B; Suzuki T; Liu X; Zhan P
    Epigenomics; 2015; 7(8):1379-96. PubMed ID: 26646727
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epigenetic assays for chemical biology and drug discovery.
    Gul S
    Clin Epigenetics; 2017; 9():41. PubMed ID: 28439316
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epigenetic approach for angiostatic therapy: promising combinations for cancer treatment.
    Berndsen RH; Abdul UK; Weiss A; Zoetemelk M; Te Winkel MT; Dyson PJ; Griffioen AW; Nowak-Sliwinska P
    Angiogenesis; 2017 May; 20(2):245-267. PubMed ID: 28378227
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Not Available].
    Marek M; Shaik TB; Jung M; Sippl W; Pierce RJ; Romier C
    Biol Aujourdhui; 2016; 210(4):311-320. PubMed ID: 28327287
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.